Drug-loaded M1 macrophage-derived sEVs have recently been shown to switch the phenotype of TAMs from M2 to M1 in GBM by promoting the secretion of TNF-α, IL-6, IFN-γ, and IL-1β from GBM cells. This evidence concerns the gene IL6 and glioblastoma.